Suppr超能文献

RNA干扰使转录信息沉默:各方面及应用

RNA interference silencing the transcriptional message: aspects and applications.

作者信息

Karkare Shantanu, Daniel Saurabha, Bhatnagar Deepak

机构信息

Apticraft Systems (P) Ltd. 142, Electronics Complex, Indore 452010, India.

出版信息

Appl Biochem Biotechnol. 2004 Oct;119(1):1-12. doi: 10.1385/abab:119:1:01.

Abstract

RNA interference (RNAi) is silencing of gene expression by double-stranded RNA (dsRNA) having complementary sequence to the target gene to be silenced. This phenomenon has transformed into a complete technology for functional genomic studies. Small interfering RNAs (siRNAs) are 21- to 23-nucleotide dsRNAs, in which the sense strand is the same as the target mRNA and the antisense strand is the complement of the target mRNA sequence. These are the effector molecules for inducing RNAi, leading to posttranscriptional gene silencing with RNA-induced silencing complex. Besides siRNA, which can be chemically synthesized, various other systems in the form of potential effector molecules for posttranscriptional gene silencing are available, such as short hairpin RNAs (shRNAs), long dsRNAs, short temporal RNAs, and micro RNAs (miRNAs). These effector molecules either are processed into siRNA such as in the case of shRNA or directly aid gene silencing as in the case of miRNA. RNAi for various unknown genes may facilitate to elucidate inherited genetic diseases and provide drug candidates for viral and oncogenic diseases. This can be achieved by targeting mRNA from oncogenic genes or mRNA for viral cellular receptor and viral structural proteins for RNAi. In this article, we evaluate various aspects and applications of RNAi technology and provide comprehensive information for the system currently available for inducing RNAi.

摘要

RNA干扰(RNAi)是指双链RNA(dsRNA)通过与待沉默的靶基因具有互补序列来使基因表达沉默。这种现象已转变为一种用于功能基因组学研究的完整技术。小干扰RNA(siRNA)是21至23个核苷酸的双链RNA,其中有义链与靶mRNA相同,反义链是靶mRNA序列的互补序列。这些是诱导RNAi的效应分子,通过RNA诱导沉默复合体导致转录后基因沉默。除了可以化学合成的siRNA外,还有各种其他形式的用于转录后基因沉默的潜在效应分子系统,如短发夹RNA(shRNA)、长双链RNA、短时间RNA和微小RNA(miRNA)。这些效应分子要么像shRNA那样被加工成siRNA,要么像miRNA那样直接辅助基因沉默。针对各种未知基因的RNAi可能有助于阐明遗传性疾病,并为病毒性和致癌性疾病提供候选药物。这可以通过针对致癌基因的mRNA或针对病毒细胞受体和病毒结构蛋白的mRNA进行RNAi来实现。在本文中,我们评估了RNAi技术的各个方面和应用,并为目前可用于诱导RNAi的系统提供了全面信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验